LD-2 disclosure · 3rd Quarter - Report
GLENMARK PHARMACEUTICALS, INC., USA
Client
- Description
- Leading,integrated, research-driven, global pharmaceutical manufacturing company.
- Location
- New Jersey · United States of America
Registrant
- Description
- Federal lobbying and consulting services
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesMedicare/Medicaid
Issues related to Medicaid CPI Penalty. Issues related to the implementation of H.R. 748, Cornonavirus Aid, Relief, and Economic Security Act (CARES Act), including Medicaid provisions. Issues related to Medicaid provisions in H.R. 6800, the HEROES Act.
LobbyistsMJ KENNY · ADAM HECHAVARRIA · LISA KOUNTOUPES
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · Health & Human Services, Dept of (HHS)
Health Issues
General education about the generic pharmaceutical industry.
Lobbyistsms MARY R "RANDI" REID · MJ KENNY · ADAM HECHAVARRIA · LISA KOUNTOUPES
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · Health & Human Services, Dept of (HHS)
Pharmacy
General information about the company and the industry. Issues related to affordability and pricing of pharmaceuticals. Issues related to the implementation of H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including drug supply chain dynamics. H.R. 6800, the HEROES Act. S. Amdt 2652, the Targeted COVID Relief Package. Issues related to the federal response to the COVID-19 pandemic. Supply chain and essential medicine manufacturing.